40 results on '"Thakur, Satbir"'
Search Results
2. Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells
3. 1118 The iodinated fluorescein derivative PV-10 enhances the antiviral activity of CD8+ T-Cells by inducing STING dimerization: implications for enhanced vaccine applications
4. Supplemental Figure 5 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
5. Supplemental Figure 1 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
6. Supplemental Figure 2 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
7. Supplemental Figure 3 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
8. supplemental legend from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
9. Supplemental Figure 4 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
10. Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
11. Abstract 1121: Identification and in vivo validation of unique anti-oncogenic properties and mechanisms involving protein kinase signalling and autophagy mediated by the investigational new agent PV-10
12. Abstract P1-08-01: Validation of automated Ki67 analysis to predict Oncotype DX recurrence score in early-stage breast cancer
13. Identification and in vitro validation of neoantigens for immune activation against high-risk pediatric leukemia cells
14. The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway
15. Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib
16. SUMOylation of the ING1b tumor suppressor regulates gene transcription
17. ATRT-09. IDENTIFICATION OF POTENTIAL GENETIC DRIVERS OF METHOTREXATE (MTX) RESISTANCE IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) THROUGH A GENOME-WIDE RNAI SCREEN
18. Pre-clinical evaluation of PV-10 for in vitro anti-tumor activity in refractory and high-risk adult solid tumors.
19. Preclinical evaluation of the ETS inhibitor TK216 against relapsed and refractory childhood leukemia.
20. Lin28A/let-7 oncogenic circuit is a potential therapeutic target in neurocutaneous melanosis-associated CNS tumors in children
21. The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway.
22. Abstract 5393: Association of heat shock proteins as chaperone for STING: A potential link in a key immune activation mechanism revealed by the novel anti-cancer agent PV-10
23. Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells
24. A Novel Anti-Cancer Vaccine Approach for the Treatment of High-Risk Leukemia in Children
25. Establishing a Novel in Vitro Informed Precision Clinical Trial Pathway for Refractory Pediatric Leukemia
26. Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model
27. Identification and in vitrovalidation of neoantigens for immune activation against high-risk pediatric leukemia cells
28. Human SNF5arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells
29. Reduced ING1 levels in breast cancer promotes metastasis
30. Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients
31. Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer
32. The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer
33. Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
34. Abstract 541: Successful oncolytic virotherapy in a bortezomib resistant syngeneic mouse model of multiple myeloma: Implications for translational significance
35. Src Regulates the Activity of the ING1 Tumor Suppressor
36. Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival
37. Evaluating usefulness of ING1 expression in stroma as a prognostic biomarker in breast cancer.
38. ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal
39. ING1 and 5-Azacytidine Act Synergistically to Block Breast Cancer Cell Growth
40. Lin28A/ let-7 oncogenic circuit is a potential therapeutic target in neurocutaneous melanosis-associated CNS tumors in children.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.